4G. M. Simpson,J. H. Lee,B. Zoubok,G. Gardos. A rating scale for tardive dyskinesia[J] 1979,Psychopharmacology(2):171～179
二级参考文献14
1Ganzini MD, Ronald T, Heintz MD, et al. The Prevalence of tardive dyskinesia in neurleptic-Treated diabetics [ J]. Arch Gen Psychiatry,1991,48:259-263.
2Harris MI, Hadd WC, Knowler WC, et al. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in US population aged 20 - 40yr[ J ] Diabetes, 1987,36:523-534 .
3Elkashef AM, Wyatt RJ. Tardive dyskinesia: possible involvement of free radicals and treatment with Vitamin E. Schizophr Bull, 1999, 25:731-740.
4Diana M, Collu M. D1 receptors mediated vacuous chewing in the rat: a model of tardive dyskinesia. Pharmacol Res, 1990, 22 Supple 3: 45-48.
5Kaneda H, Shirakawa O, Dale J, et al. Co-administration of progabide inhibits haloperidol-induced oral dyskinesias in rats. Eur J Pharmacol, 1992, 212: 43-49.
6Abilio VC, Araujo CC, Bergamo M, et al. Vitamin E attenuates reserpine-induced oral dyskinesia and striatal oxidized glutathione/reduced glutathione ratio (GSSG/GSH) enhancement in rats. Prog Neuropsychopharmacol Biol Psychiatry, 2003, 27:109-114.
7Andreassen OA, Jorgensen HA.Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats:implications for tardive dyskinesia? Prog Neurobiol, 2000, 61:525-541.
8Tsai G, Goff DC, Zhang RW, et al. Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia. Am J Psychiatry, 1998, 155:1207-1213.
9Heckers S, Heinsen H, Heinsen Y, et al. Cortex, white matter, and basal ganglia in schizophrenia: a volumetric postmortem study. Biol Psychiatry, 1991, 29:556-566.
10Sachdev P, Saharov T, Cathcart S.The preventative role of antioxidants (selegiline and Vitamin E) in a rat model of tardive dyskinesia. Biol Psychiatry, 1999, 46:1672-1681.
